ADVANCED MALIGNANCY
Clinical trials for ADVANCED MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCY trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cancer drug ADCX-020 enters first human tests
Disease control Recruiting nowThis early-phase study tests a new cancer drug called ADCX-020 in 290 adults with advanced solid tumors that have not responded to standard treatments. The drug is an antibody drug conjugate designed to target and kill cancer cells. The study first finds the safest dose, then tes…
Matched conditions: ADVANCED MALIGNANCY
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated May 26, 2026 06:24 UTC
-
New shot for advanced cancer enters human testing
Disease control Recruiting nowThis early-stage study tests an experimental drug called SHR-7782 in 200 adults with advanced solid tumors that have not responded to other treatments. The main goals are to find the safest dose and to see if the drug can shrink tumors or slow their growth. Participants must have…
Matched conditions: ADVANCED MALIGNANCY
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:23 UTC